ODTX
Odyssey Therapeutics, Inc. Common Stock
Nasdaq · usd
Odyssey Therapeutics, Inc. Common Stock (ODTX) trades at $18.98 (-2.01%) as of 4:20:00 PM EST on Nov 18, 2026, -0.05% over the past month. Market cap is $912.33M, with 15.4 days to cover in short interest.
Stock performance
How Odyssey Therapeutics, Inc. Common Stock (ODTX) stock has performed from one day to one year, with its 52-week range.
- 1D
- -2.01%
- 1W
- -9.58%
- 1M
- -0.05%
- YTD
- +15.59%
- 1Y
- +15.59%
- 52-wk range
- $15.10 – $29.05
Key statistics
Today's trading snapshot for ODTX: day range, open, previous close, volume and market cap.
- Day range
- $18.81 – $19.98
- Open
- $19.26
- Prev close
- $19.37
- Volume
- 369.1K
- Market cap
- $912.33M
- Shares out
- 48.07M
Valuation and profitability ratios: P/E, P/S, ROE
Valuation and profitability ratios for Odyssey Therapeutics, Inc. Common Stock: P/E, P/S, P/B, ROE and more.
- P/E
- —
- P/S
- —
- P/B
- 2.43
- P/FCF
- —
- ROE
- -38.4%
- ROA
- -32.9%
- Debt/Equity
- 0.00
- Div yield
- 0.00%
As of Nov 18, 2026
8-K filings
Material corporate events Odyssey Therapeutics, Inc. Common Stock has disclosed to the SEC on Form 8-K.
- Quarterly earningsNov 4, 2026
On November 4, 2026, Odyssey Therapeutics, Inc. (the "Company") announced its financial results for the three months ended September 30, 2026.
- Investor presentationOct 20, 2026
The Company issued the press release and “posted a corporate presentation on its website at https://investors.odysseytx.com/news-events/presentations.”
- Investor presentationSep 9, 2026
On September 8, 2026, Odyssey Therapeutics, Inc. (the "Company") posted a corporate presentation on its website at https://investors.odysseytx.com/news-events/presentations. A copy of the presentation is furnished herewith as Exhibit 99.1 to this Current Report on Form 8-K.
- Investor presentationJun 23, 2026
On June 23, 2026, Odyssey Therapeutics, Inc. (the "Company") posted a corporate presentation on its website at https://investors.odysseytx.com/news-events/presentations. A copy of the presentation is furnished herewith as Exhibit 99.1 to this Current Report on Form 8-K.
- Charter amendmentMay 11, 2026
In connection with the closing of the IPO, on May 11, 2026, the Company filed an amended and restated certificate of incorporation with the Secretary of State of the State of Delaware. The Company's board of directors and stockholders previously approved the Amended and Restated Certificate of Incorporation to be effective as of immediately prior to the closing of the IPO.
ODTX short interest
How heavily ODTX is shorted: shares short, days to cover and average daily volume.
- Days to cover
- 15.4
- Short interest
- 3.35M
- Avg volume
- 216.97K
As of · reported to FINRA twice monthly.
Frequently asked questions
What is the Odyssey Therapeutics, Inc. Common Stock (ODTX) stock price today?
Odyssey Therapeutics, Inc. Common Stock (ODTX) is trading at $18.98 (-2.01% on the day) as of 4:20:00 PM EST on Nov 18, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.
What is Odyssey Therapeutics, Inc. Common Stock?
Odyssey Therapeutics Inc is a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases.
What is the short interest in ODTX?
As of Oct 30, 2026, ODTX has 3.35M shares short and 15.4 days to cover.
What exchange is ODTX listed on?
Odyssey Therapeutics, Inc. Common Stock (ODTX) trades on Nasdaq in USD, in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) industry.
Build with AI
Build an analysis of ODTX with your agent
Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.
Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a ODTX analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.